Calyx Announces Non-Brokered Private Placement
In Canada, Calyx Bio-Ventures announced the proposed non-brokered private placement of up to 5,001,000 units at a price of $0.15 per unit for cash proceeds of up to $750,150. Each unit comprises one common share and one common share purchase warrant, with the warrant entitling the holder to acquire one additional common share of the […]









